Cholesterol-lowering statin drugs can reduce the incidence of the most common type of cataract by 45 percent, according to a five-year study of nearly 1,300 people.
Researchers were surprised at the findings because several potential cholesterol-lowering drugs never made it to market because studies showed that they caused cloudiness and other eye problems.